TREAT Asia Pediatric HIV Observational Database (TApHOD)
As of 2024, TApHOD, includes over 7,500 human immunodeficiency virus (HIV)-infected participants from six low and middle-income countries of Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. The study aims to examine the causation of HIV, and monitor the success of antiretroviral therapy (ART), in improving the management of children living with HIV within the region. Participants are followed up as part of routine patient care at clinical sites, with a median follow-up duration of 3 years. The cohort consists of children aged 18 years or younger, with a median age of 7 years at the start of ART.
Study design
Cohort - clinical
Number of participants at first data collection
2,280 (participants)
Recruitment is ongoing
Age at first data collection
0 - 17 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2007
Primary Institutions
University of New South Wales (UNSW) (Academic, Australia)
Profile paper DOI
Funders
Austrian AIDS Life Asoociation (Third Sector, Austria)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Government, United States of America)
National Institute of Allergy and Infectious Diseases (NIAID) (Government, United States of America)
National Institutes of Health (NIH) (Government, United States of America)
The Foundation for AIDS Research (amFAR) (Third Sector, United States of America)
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-completed questionnaire – unspecified
- None
- None
- Healthcare data
- Mortality data
Engagement
Keywords
